By Stephen Nakrosis
Special purpose acquisition company Denali Capital Acquisition said Friday it was extending the deadline by which it had to consummate a business combination by one month, to Dec. 11.
An aggregate of $50,000 was deposited into the company’s trust account to extend the period, the SPAC said.
In January, biopharmaceutical company Longevity Biomedical and Denali Capital Acquisition announced they entered into a business combination agreement which would see the combined company trading on the Nasdaq.
Write to Stephen Nakrosis at [email protected]
Read the full article here